Michael Gelband’s Meredith Corporation MDP Stock Holding History

Michael Gelband’s Portfolio MDP Stock Details MDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,213	Closed	-$423K	–	3029
2021 Q1	$423K	Buy	+14,213	New	+$375K	0.01%	1475
2020 Q4	–	Sell	-14,275	Closed	-$187K	–	2541
2020 Q3	$187K	Sell	14,275 -4,698	-25%	-$65.6K	﹤0.01%	1498
2020 Q2	$276K	Buy	+18,973	New	+$276K	0.01%	1363
2019 Q4	–	Sell	-90,775	Closed	-$3.33M	–	2017
2019 Q3	$3.33M	Buy	+90,775	New	+$4.22M	0.12%	156
2019 Q1	–	Sell	-6,625	Closed	-$344K	–	795
2018 Q4	$344K	Buy	+6,625	New	+$359K	0.02%	181

Other funds holding MDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's MDP Position: Q2 2021 in Review

Michael Gelband sold out of Meredith Corporation (MDP) in Q2 2021, closing a stake of 14,213 shares — an estimated $423K sold.

Michael Gelband first reported a position in MDP in Q4 2018 and held it in 5 quarters. The position peaked at $3.33M in Q3 2019. 202 funds tracked by Wall St. Rank hold MDP as of Q2 2021.

Michael Gelband reported no remaining Meredith Corporation position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 14,213 Meredith Corporation shares in Q2 2021, an estimated $423K.
Michael Gelband first reported a position in Meredith Corporation in Q4 2018 and held it in 5 quarters.
Michael Gelband's Meredith Corporation position peaked at $3.33M in Q3 2019.
202 funds tracked by Wall St. Rank held Meredith Corporation as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.